| Literature DB >> 30413522 |
Alexandros Georgiadis1, Robbie Duschinsky2, Jesus Perez3, Peter B Jones4, Debra Russo4, Clare Knight4, Emma Soneson4, Mary Dixon-Woods1.
Abstract
INTRODUCTION: Some people, who have common mental health disorders such as depression and anxiety, also have some psychotic experiences. These individuals may experience a treatment gap: their symptoms neither reach the increasingly high threshold for secondary care, nor do they receive full benefit from current interventions offered by the Improving Access to Psychological Therapies (IAPT) programme. The result may be poorer clinical and functional outcomes. A new talking therapy could potentially benefit this group. Informed by principles of coproduction, this study will seek the views of service users and staff to inform the design and development of such a therapy. METHODS AND ANALYSIS: Semistructured interviews will be conducted with IAPT service users, therapists and managers based in three different geographical areas in England. Our sample will include (1) approximately 15 service users who will be receiving therapy or will have completed therapy at the time of recruitment, (2) approximately 15 service users who initiated treatment but withdrew, (3) approximately 15 therapists each with at least 4-month experience in a step-3 IAPT setting and (4) three IAPT managers. Data analysis will be based on the constant comparative method. ETHICS AND DISSEMINATION: The study has been approved by the London Harrow Research Ethics Committee (reference: 18/LO/0642), and all National Health Service Trusts have granted permissions to conduct the study. Findings will be published in peer-reviewed academic journals, and presented at academic conferences. We will also produce a 'digest' summary of the findings, which will be accessible, visual and freely available. © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY. Published by BMJ.Entities:
Keywords: anxiety disorders; mental health; primary Care; qualitative research
Mesh:
Year: 2018 PMID: 30413522 PMCID: PMC6231599 DOI: 10.1136/bmjopen-2018-026064
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Inclusion and exclusion criteria for people who are in therapy or have completed their therapy
| Inclusion | Exclusion |
| Male or female | PHQ-9 score ≤10 and/or GAD-7 score ≤8 |
CAPE-P15, Community Assessment of Psychic Experiences-Positive 15 items; GAD-7, 7-item Generalised Anxiety Disorder; IAPT, Improving Access to Psychological Therapies; PHQ-9, 9-item Patient Health Questionnaire.
Inclusion and exclusion criteria for people who initiated treatment but withdrawn
| Inclusion | Exclusion |
| Male or female | PHQ-9 score ≤10 and/or GAD-7 score ≤8 |
CAPE-P15, Community Assessment of Psychic Experiences-Positive 15 items; GAD-7, 7-item Generalised Anxiety Disorder; IAPT, Improving Access to Psychological Therapies; PHQ-9, 9-item Patient Health Questionnaire.